Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
125 tokens/sec
GPT-4o
47 tokens/sec
Gemini 2.5 Pro Pro
43 tokens/sec
o3 Pro
4 tokens/sec
GPT-4.1 Pro
47 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

Enhancing MRI-Based Classification of Alzheimer's Disease with Explainable 3D Hybrid Compact Convolutional Transformers (2403.16175v1)

Published 24 Mar 2024 in eess.IV and cs.CV

Abstract: Alzheimer's disease (AD), characterized by progressive cognitive decline and memory loss, presents a formidable global health challenge, underscoring the critical importance of early and precise diagnosis for timely interventions and enhanced patient outcomes. While MRI scans provide valuable insights into brain structures, traditional analysis methods often struggle to discern intricate 3D patterns crucial for AD identification. Addressing this challenge, we introduce an alternative end-to-end deep learning model, the 3D Hybrid Compact Convolutional Transformers 3D (HCCT). By synergistically combining convolutional neural networks (CNNs) and vision transformers (ViTs), the 3D HCCT adeptly captures both local features and long-range relationships within 3D MRI scans. Extensive evaluations on prominent AD benchmark dataset, ADNI, demonstrate the 3D HCCT's superior performance, surpassing state of the art CNN and transformer-based methods in classification accuracy. Its robust generalization capability and interpretability marks a significant stride in AD classification from 3D MRI scans, promising more accurate and reliable diagnoses for improved patient care and superior clinical outcomes.

Definition Search Book Streamline Icon: https://streamlinehq.com
References (42)
  1. A. Association, “2023 alzheimer’s disease facts and figures,” Alzheimer’s & Dementia, vol. 19, 03 2023.
  2. L. Kurlowicz and M. Wallace, “The mini-mental state examination (mmse),” Journal of Gerontological Nursing, vol. 25, pp. 8–9, 05 1999.
  3. H. Hampel and K. Blennow, “Csf tau and β𝛽\betaitalic_β-amyloid as biomarkers for mild cognitive impairment,” Dialogues in Clinical Neuroscience, vol. 6, pp. 379–390, 12 2004.
  4. C. M. C. Bottino, C. C. Castro, R. L. E. Gomes, C. A. Buchpiguel, R. L. Marchetti, and M. R. L. Neto, “Volumetric mri measurements can differentiate alzheimer’s disease, mild cognitive impairment, and normal aging,” International Psychogeriatrics, vol. 14, p. 59–72, 03 2002.
  5. R. Jain, N. Jain, A. Aggarwal, and D. J. Hemanth, “Convolutional neural network based alzheimer’s disease classification from magnetic resonance brain images,” Cognitive Systems Research, vol. 57, 01 2019.
  6. A. Payan and G. Montana, “Predicting alzheimer’s disease: a neuroimaging study with 3d convolutional neural networks,” arXiv preprint arXiv:1502.02506, 02 2015.
  7. E. Hosseini-Asl, G. Gimel’farb, and A. El-Baz, “Alzheimer’s disease diagnostics by a deeply supervised adaptable 3d convolutional network,” arXiv preprint arXiv:1607.00556, 07 2016.
  8. S. Korolev, A. Safiullin, M. Belyaev, and Y. Dodonova, “Residual and plain convolutional neural networks for 3d brain mri classification,” in 2017 IEEE 14th international symposium on biomedical imaging (ISBI 2017).   IEEE, 2017, pp. 835–838.
  9. A. Dosovitskiy, L. Beyer, A. Kolesnikov, D. Weissenborn, X. Zhai, T. Unterthiner, M. Dehghani, M. Minderer, G. Heigold, S. Gelly et al., “An image is worth 16x16 words: Transformers for image recognition at scale,” arXiv preprint arXiv:2010.11929, 10 2020.
  10. A. Vaswani, N. Shazeer, N. Parmar, J. Uszkoreit, L. Jones, A. N. Gomez, Ł. Kaiser, and I. Polosukhin, “Attention is all you need,” Advances in neural information processing systems, vol. 30, 2017.
  11. A. Hassani, S. Walton, N. Shah, A. Abuduweili, J. Li, and H. Shi, “Escaping the big data paradigm with compact transformers,” arXiv preprint arXiv:2104.05704, 2021.
  12. B. Fischl, “Freesurfer,” Neuroimage, vol. 62, no. 2, pp. 774–781, 2012.
  13. M. W. Woolrich, S. Jbabdi, B. Patenaude, M. Chappell, S. Makni, T. Behrens, C. Beckmann, M. Jenkinson, and S. M. Smith, “Bayesian analysis of neuroimaging data in fsl,” Neuroimage, vol. 45, no. 1, pp. S173–S186, 2009.
  14. S. M. Smith, M. Jenkinson, M. W. Woolrich, C. F. Beckmann, T. E. Behrens, H. Johansen-Berg, P. R. Bannister, M. De Luca, I. Drobnjak, D. E. Flitney et al., “Advances in functional and structural mr image analysis and implementation as fsl,” Neuroimage, vol. 23, pp. S208–S219, 2004.
  15. M. Jenkinson, C. F. Beckmann, T. E. Behrens, M. W. Woolrich, and S. M. Smith, “Fsl,” Neuroimage, vol. 62, no. 2, pp. 782–790, 2012.
  16. X. He, A. Q. Wang, and M. R. Sabuncu, “Neural pre-processing: A learning framework for end-to-end brain mri pre-processing,” in International Conference on Medical Image Computing and Computer-Assisted Intervention.   Springer, 2023, pp. 258–267.
  17. A. Ebrahimi, S. Luo, and f. t. A. Disease Neuroimaging Initiative, “Convolutional neural networks for alzheimer’s disease detection on mri images,” Journal of Medical Imaging, vol. 8, no. 2, pp. 024 503–024 503, 2021.
  18. U. Gupta, T. Chattopadhyay, N. Dhinagar, P. M. Thompson, and G. Ver Steeg, “Transferring models trained on natural images to 3d mri via position encoded slice models,” in 2023 IEEE 20th International Symposium on Biomedical Imaging (ISBI).   IEEE, 2023, pp. 1–5.
  19. S. Liu, A. V. Masurkar, H. Rusinek, J. Chen, B. Zhang, W. Zhu, C. Fernandez-Granda, and N. Razavian, “Generalizable deep learning model for early alzheimer’s disease detection from structural mris,” Scientific reports, vol. 12, no. 1, p. 17106, 2022.
  20. K. Simonyan, A. Vedaldi, and A. Zisserman, “Deep inside convolutional networks: Visualising image classification models and saliency maps,” Proceedings of the International Conference on Learning Representations, 2014.
  21. Y. Ban, X. Zhang, and H. Lao, “Diagnosis of alzheimer’s disease using structure highlighting key slice stacking and transfer learning,” Medical Physics, vol. 49, no. 9, pp. 5855–5869, 2022.
  22. M. M. S. Fareed, S. Zikria, G. Ahmed, S. Mahmood, M. Aslam, S. F. Jillani, A. Moustafa, M. Asad et al., “Add-net: An effective deep learning model for early detection of alzheimer disease in mri scans,” IEEE Access, vol. 10, pp. 96 930–96 951, 2022.
  23. J. Wen, Y. Li, M. Fang, L. Zhu, D. D. Feng, and P. Li, “Fine-grained and multiple classification for alzheimer’s disease with wavelet convolution unit network,” IEEE Transactions on Biomedical Engineering, 2023.
  24. S. Zhang, X. Chen, B. Ren, H. Yang, Z. Yu, X.-Y. Zhang, and Y. Zhou, “3d global fourier network for alzheimer’s disease diagnosis using structural mri,” in International Conference on Medical Image Computing and Computer-Assisted Intervention.   Springer, 2022, pp. 34–43.
  25. Y. Zhou, Y. Li, F. Zhou, Y. Liu, and L. Tu, “Learning with domain-knowledge for generalizable prediction of alzheimer’s disease from multi-site structural mri,” in International Conference on Medical Image Computing and Computer-Assisted Intervention.   Springer, 2023, pp. 452–461.
  26. W. Kang, L. Lin, S. Sun, and S. Wu, “Three-round learning strategy based on 3d deep convolutional gans for alzheimer’s disease staging,” Scientific Reports, vol. 13, no. 1, p. 5750, 2023.
  27. K. P. Nguyen, A. H. Treacher, and A. A. Montillo, “Adversarially-regularized mixed effects deep learning (armed) models improve interpretability, performance, and generalization on clustered (non-iid) data,” IEEE Transactions on Pattern Analysis and Machine Intelligence, 2023.
  28. F. J. M. Shamrat, S. Akter, S. Azam, A. Karim, P. Ghosh, Z. Tasnim, K. M. Hasib, F. De Boer, and K. Ahmed, “Alzheimernet: An effective deep learning based proposition for alzheimer’s disease stages classification from functional brain changes in magnetic resonance images,” IEEE Access, vol. 11, pp. 16 376–16 395, 2023.
  29. H. Zhou, Y. Zhang, B. Y. Chen, L. Shen, and L. He, “Sparse interpretation of graph convolutional networks for multi-modal diagnosis of alzheimer’s disease,” in International Conference on Medical Image Computing and Computer-Assisted Intervention.   Springer, 2022, pp. 469–478.
  30. T. Xiao, L. Zeng, X. Shi, X. Zhu, and G. Wu, “Dual-graph learning convolutional networks for interpretable alzheimer’s disease diagnosis,” in International Conference on Medical Image Computing and Computer-Assisted Intervention.   Springer, 2022, pp. 406–415.
  31. H.-D. Nguyen, M. Clément, B. Mansencal, and P. Coupé, “Interpretable differential diagnosis for alzheimer’s disease and frontotemporal dementia,” in International Conference on Medical Image Computing and Computer-Assisted Intervention.   Springer, 2022, pp. 55–65.
  32. Z. Liu, H. Lu, X. Pan, M. Xu, R. Lan, and X. Luo, “Diagnosis of alzheimer’s disease via an attention-based multi-scale convolutional neural network,” Knowledge-Based Systems, vol. 238, p. 107942, 2022.
  33. A. Gamal, M. Elattar, and S. Selim, “Automatic early diagnosis of alzheimer’s disease using 3d deep ensemble approach,” IEEE Access, vol. 10, pp. 115 974–115 987, 2022.
  34. X. Zhang, L. Han, W. Zhu, L. Sun, and D. Zhang, “An explainable 3d residual self-attention deep neural network for joint atrophy localization and alzheimer’s disease diagnosis using structural mri,” IEEE journal of biomedical and health informatics, vol. 26, no. 11, pp. 5289–5297, 2021.
  35. Y. Zhang, X. He, Y. Liu, C. Z. L. Ong, Y. Liu, and Q. Teng, “An end-to-end multimodal 3d cnn framework with multi-level features for the prediction of mild cognitive impairment,” Knowledge-Based Systems, vol. 281, p. 111064, 2023.
  36. R. Kadri, B. Bouaziz, M. Tmar, and F. Gargouri, “Efficient multimodel method based on transformers and coatnet for alzheimer’s diagnosis,” Digital Signal Processing, vol. 143, p. 104229, 2023.
  37. M. S. Seyfioğlu, Z. Liu, P. Kamath, S. Gangolli, S. Wang, T. Grabowski, and L. Shapiro, “Brain-aware replacements for supervised contrastive learning in detection of alzheimer’s disease,” in International Conference on Medical Image Computing and Computer-Assisted Intervention.   Springer, 2022, pp. 461–470.
  38. Y. Duan, R. Wang, and Y. Li, “Aux-vit: Classification of alzheimer’s disease from mri based on vision transformer with auxiliary branch,” in 2023 5th International Conference on Communications, Information System and Computer Engineering (CISCE).   IEEE, 2023, pp. 382–386.
  39. S. Khan, M. Naseer, M. Hayat, S. W. Zamir, F. S. Khan, and M. Shah, “Transformers in vision: A survey,” ACM computing surveys (CSUR), vol. 54, no. 10s, pp. 1–41, 2022.
  40. P. Baldi and P. J. Sadowski, “Understanding dropout,” Advances in neural information processing systems, vol. 26, 2013.
  41. C. R. Jack Jr, M. A. Bernstein, N. C. Fox, P. Thompson, G. Alexander, D. Harvey, B. Borowski, P. J. Britson, J. L. Whitwell, C. Ward et al., “The alzheimer’s disease neuroimaging initiative (adni): Mri methods,” Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine, vol. 27, no. 4, pp. 685–691, 2008.
  42. I. Loshchilov and F. Hutter, “Decoupled weight decay regularization,” arXiv preprint arXiv:1711.05101, 2017.
Citations (1)
View on Semantic Scholar

Summary

  • The paper presents a novel 3D HCCT architecture that merges CNNs and ViTs to capture both local and global features in 3D MRI scans.
  • The model achieves a superior 96.06% classification accuracy on the ADNI dataset while streamlining the end-to-end diagnostic pipeline.
  • Enhanced interpretability through visualization features aids clinicians in understanding complex diagnostic decisions for Alzheimer’s disease.

Enhancing MRI-Based Classification of Alzheimer's Disease with Explainable 3D Hybrid Compact Convolutional Transformers

The paper presented in "Enhancing MRI-Based Classification of Alzheimer's Disease with Explainable 3D Hybrid Compact Convolutional Transformers" introduces a novel approach for Alzheimer's disease (AD) diagnosis through neuroimaging. This paper explores the utility of combining Convolutional Neural Networks (CNNs) with Vision Transformers (ViTs) to develop an end-to-end deep learning model named 3D Hybrid Compact Convolutional Transformers (3D HCCT). The authors address the significant global health concern posed by AD by proposing a method aimed at improving both the accuracy and interpretability of diagnostic models based on 3D magnetic resonance imaging (MRI) scans.

Key Contributions

The main contributions of this research can be encapsulated in a few critical innovations:

  1. Novel Architecture: The 3D HCCT architecture marries the localized feature extraction strengths of CNNs with the ability of ViTs to capture long-range dependencies, thereby enabling the identification of complex patterns within volumetric brain images that are crucial for the diagnosis of AD.
  2. End-to-End Deep Learning Pipeline: The paper develops a comprehensive pipeline that processes all stages from pre-processing (such as skull stripping and standardization) to classification and explainability, eliminating the need for manual interventions and streamlining the workflow significantly.
  3. Superior Classification Performance: The model demonstrates superior performance on the ADNI dataset in terms of classification accuracy compared to state-of-the-art approaches, highlighting both its robust generalizability and increased interpretability.

Methodology

The researchers employ a 3D HCCT model with a visionary integration of CNNs and ViTs, with a distinct focus on the challenges that arise when adapting ViTs to work effectively with 3D medical data. The combination involves novel adaptations such as a hybrid pooling method designed to leverage both local and global features from 3D MRI scans. The model's detailed architecture incorporates steps like pre-processing with Neural Pre-processing Python (NPPY) and a strategic multi-head attention mechanism within ViTs to address the complexities inherent in 3D data.

Numerical Results

Experimental results affirm that the 3D HCCT model not only surpasses existing CNN-based models in accuracy but also offers superior interpretability capabilities, as highlighted by its enhanced visualization features. The model achieved a classification accuracy of 96.06% on the validation sets, a significant improvement over traditional techniques. This performance underscores the efficacy of the hybrid model in capturing critical diagnostic features from MRI scans.

Implications and Future Directions

The practical implications of this research are profound, given the rising prevalence of Alzheimer's disease and the vital need for accurate early diagnosis tools. By improving the precision and reliability of MRI-based assessments, this technology promises to enhance clinical outcomes and patient care significantly. Moreover, the model's enhanced interpretability can aid clinicians in understanding the decision-making process, potentially leading to more informed therapeutic decisions.

From a theoretical standpoint, this paper provides a framework for future research directions. Investigating alternative deep learning architectures such as Graph Convolutional Networks (GCNs) for capturing complex temporal and spatial relationships within MRI data is a promising avenue. Additionally, exploring large-scale validation and deployment in clinical settings will be critical for determining the model's utility in practical diagnostic applications.

In conclusion, the 3D HCCT represents a significant advancement in employing state-of-the-art AI techniques for biomedical imaging, setting a benchmark for prospective studies focused on transforming Alzheimer's disease diagnosis. The paper paves the way for new, innovative approaches to machine learning-based medical diagnostics, promising a positive impact on both theoretical developments and clinical practices.

File Document Download Save Streamline Icon: https://streamlinehq.com PDF File Document Download Save Streamline Icon: https://streamlinehq.com Markdown
X Twitter Logo Streamline Icon: https://streamlinehq.com

Tweets

Youtube Logo Streamline Icon: https://streamlinehq.com

YouTube